![Patrick van Berkel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick van Berkel
Keine laufenden Positionen mehr
Profil
Patrick van Berkel currently works at ADC Therapeutics SA, as Chief Scientific Officer.
Dr. van Berkel also formerly worked at Genmab A, as VP-Antibody, Technology & Chemistry from 2003 to 2012.
Dr. van Berkel received his doctorate degree in 1998 from the University of Leiden and undergraduate degree in 1991 from Radboud University Nijmegen.
Ehemalige bekannte Positionen von Patrick van Berkel
| Unternehmen | Position | Ende |
|---|---|---|
| ADC THERAPEUTICS SA | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2026 |
| GENMAB A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2012 |
Ausbildung von Patrick van Berkel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Radboud University Nijmegen
 Radboud University Nijmegen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
